Hubungan Kadar Troponin T dengan Lama Perawatan dan Mortalitas Selama Perawatan pada Pasien Infark Miokard Akut di RSUD Abdul Wahab Sjahranie Samarinda
DOI:
https://doi.org/10.25026/jsk.v2i4.216Abstract
In the setting of acute myocardial infarction (AMI), an increased in cardiac biomarker levels is a parameter supporting the diagnosis of AMI. There are several types of cardiac biomarkers, including CK-MB, troponin T, troponin I, LDH, and myoglobin. Troponin is one of the recommended cardiac biomarker owing to its high specificity. Besides indicating the occurrence of AMI, troponin T is also known to have an association with ischemic duration, degree of ischemia, extent of infarction, complications, and even mortality among AMI patients. These parameters are thought to be the factors that influence the length of stay and in-hospital mortality in AMI patients. Therefore, the author was interested to determine the relationship between troponin T levels with treatment duration and in-hospital mortality in AMI patients. This analytical study was conducted using cross-sectional approach and secondary data. The study samples are AMI patients treated at Abdul Wahab Sjahranie Hospital in Samarinda between January 1, 2018 - December 31, 2018 who met the inclusion and exclusion criteria. In total, this study involved 86 people. The results show that the average troponin T levels in AMI patients is 1159.93 pg/ml, the average length of stay is 5.11 days, and the percentage of mortality during treatment is 10.5%. Bivariate analysis shows that troponin T does not have a significant relationship with length of stay (p = 0.422) and in-hospital mortality (p = 1,000). Thus, it can be concluded that troponin T levels are not associated with length of stay and in-hospital mortality in AMI patients.
Keywords : AMI, Troponin T levels, Length of Stay, In-Hospital Mortality
References
[2] Jayaraj, J. C., Davatyan, K., Subramanian, S. S., Priya, J. 2018. Epidemiology of Myocardial Infarction. IntechOpen.
[3] Chacko, S., Haseeb, S., Glover, B. M., Wallbridge, D., & Harper, A. 2017. The role of biomarkers in the diagnosis and risk stratification of acute coronary syndrome, Future Science OA, Volume 4, (1).
[4] Lilly, L.S. 2011. Pathophysiology of Heart Disease: a Collaborative Project of Medical Students and Faculty. Wolters Kluwer.
[5] Kvisvik, B., et al. 2017. High-Sensitivity Troponin T vs I in Acute Coronary Syndrome: Prediction of Significant Coronary Lesions and Long-term Prognosis, Clinical Chemistry, 552-562.
[6] Arruda-Olson, A. M., Roger, V. L., Jaffe, A. S., Hodge, D. O., Gibbons, R. J., & Miller, T. D. 2011. Troponin T Levels and Infarct Size by SPECT Myocardial Perfusion Imaging, JACC: CARDIOVASCULAR IMAGING, 523-33.
[7] Minicucci, M. F., et al. 2014. Infarct Size as Predictor of Systolic Functional Recovery after, Arquivos Brasileiros De Cardiologica, 549-556.
[8] Reinstadler, S. J., et al. 2016. High-sensitivity troponin T for prediction of left ventricular function and infarct size one year following ST-elevation myocardial infarction, International Journal of Cardiology, 188-193.
[9] Nguyen, T. L., et al. 2015. High-sensitivity troponin T predicts infarct scar characteristics and adverse left ventricular function by cardiac magnetic resonance imaging early after reperfused acute myocardial infarction, American Heart Journal, 715-725.
[10] Miller, A. L., et al. 2012. Left Ventricular Ejection Fraction Assessment Among Patients With Acute Myocardial Infarction and Its Association With Hospital Quality of Care and Evidence-Based Therapy Use, Circulation: Cardiovascular Quality and Outcome, 662-671.
[11] Gerber, Y., Jaffe, A. S., Weston, S. A., Jiang, R., & Roger, V. L. 2012. Prognostic Value of Cardiac Troponin T After Myocardial Infarction: A Contemporary Community Experience, Mayo Clinic Proc., 247-254.
[12] Wanamaker, B. L., et al. 2019. Relationship Between Troponin on Presentation and In-Hospital Mortality in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention, Journal of the American Heart Association, 1-9.
[13] Hastuti, Y. E., Elfi, E. F., & Pertiwi, D. 2017. Hubungan Kadar Troponin T dengan Lama Perawatan Pasien Infark Miokard Akut di RSUP Dr. M. Djamil Padang Periode 01 Januari-31 Desember 2013, Jurnal Kesehatan Andalas, 423-428.
[14] Prabhakaran, S. P., & Kannan, A. 2017. Prognostic significance of troponin T in acute myocardial infarction, International Journal of Research in Medical Sciences, Volume 5, (10), 4363-4368.
[15] Muntiyarso, P. 2014. Kadar Creatine Kinase-MB, Troponin T, dan Gambaran ST Deviasi sebagai Faktor Prediktor Terjadinya Major Adverse Cardiac Events pada Pasien Sindrom Koroner Akut. Jakarta: Universitas Islam Negeri Syarif Hidayatullah Jakarta.
[16] Vavalle, J. P., et al. 2012. Identifying Factors that Influences Hospital Length of Stay in Patients with Non-ST-segment Elevation Myocardial Infarction: Insights from the Acute Coronary Treatment Intervention Outcome Network Registry®-Get With The Guidelines™, The American Journal of Medicine, Volume 125, (11), 1085-1094.
[17] Arruda-Olson, A. M., Roger, V. L., Jaffe, A. S., Hodge, D. O., Gibbons, R. J., & Miller, T. D. 2011. Troponin T Levels and Infarct Size by SPECT Myocardial Perfusion Imaging, JACC: CARDIOVASCULAR IMAGING, 523-33.
[18] Putri, A. S. 2017. Pengaruh Skor TIMI, Kadar Troponin T, dan Hitung Jumlah Leukosit Terhadap Mortalitas Pasien Infark Miokard Akut Non Elevasi Segmen ST di RSUP Dr. M. Djamil Padang. Padang: Scholar Unand.
[19] Mueller, C., Neumann, F.-J., Perruchoud, A. P., Zeller, T., & Buettner, H. J. 2004. Prognostic Value of Quantitative Troponin T Measurements in Unstable Angina/Non–ST Segment Elevation Acute Myocardial Infarction Treated Early and Predominantly with Percutaneous Coronary Intervention, The American Journal of Medicine, Volume 117, 897-902.
[20] Bajraktari, G., et al. 2008. In-hospital mortality following acute myocardial infarction in Kosovo: a single center study, Ann Saudi Med, 430-434.
